Transcatheter aortic valve implantation in patients with a mitral prosthesis; single center experience and review of literature

详细信息    查看全文

• 作者：Serkan Asil^a ; Levent Şahiner^a ; ^{mleventsahiner@yahoo.com" class="auth_mail" title="E-mail the corresponding author} ; Necla Ö ; zer^a ; E. Barış Kaya^a ; Banu Evranos^a ; Uğur Canpolat^a ; Hikmet Yorgun^a ; Heves Karagö ; z^b ; Kudret Aytemir^a
• 关键词：TAVİ ; Mitral prosthesis ; Aorta-mitral continuity
• 刊名：International Journal of Cardiology
• 出版年：2016
• 出版时间：15 October 2016
• 年：2016
• 卷：221
• 期：Complete
• 页码：390-395
• 全文大小：799 K

文摘

Following the encouraging results of several registries and trials, transcatheter aortic valve implantation (TAVI) has been recognized as a valid option in patients with severe aortic stenosis deemed at high or prohibitive risk for surgical treatment. Good procedural success and good clinical outcomes have been showed and very limited data exist on TAVI in the setting of a preexisting mitral prosthesis regarding the technique, potential complications, and outcomes.

Methods

Here, we report six cases of transfemoral TAVI with a self-expanding bioprosthesis (CoreValve; Medtronic, Inc) in patients who had previously undergone mitral valve replacement. Preprocedural, intraprocedural ve postprocedural outcome and data were analyzed and a brief literature review is also presented.

Results and conclusion

Our experiences show that transfemoral CoreValve implantation can be performed successfully in patients with mechanical and bioprosthetic mitral valves.